HCPCS code J1576 — Inj, panzyga, 500 mg.
Status: Active.
Effective Jul 1, 2023.
Source: CMS HCPCS Level II.
J1576
ActiveInj, panzyga, 500 mg
Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg
Category:
Drugs
Section:
J-codes: Drugs Administered Other Than Oral Method
Effective:
Jul 1, 2023
Code type:
alphanumeric
OPPS Status:
K
— Non-pass-through drugs and biologicals
OPPS APC:
9144
MUE — Medically Unlikely Edits
Maximum units of J1576 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.
| Service Type | Max Units / Day |
|---|---|
| Outpatient Hospital | 600 |
| Practitioner Services | 600 |
Source: CMS Medicare NCCI Medically Unlikely Edits
NDC Crosswalk
National Drug Codes (NDCs) mapped to this HCPCS code.
| NDC | Drug Name |
|---|---|
| 00069-1109-02 | Panzyga |
| 00069-1224-02 | Panzyga |
| 00069-1312-02 | Panzyga |
| 00069-1415-02 | Panzyga |
| 00069-1558-02 | Panzyga |
| 68982-0822-02 | Panzyga |
| 68982-0822-03 | Panzyga |
| 68982-0822-04 | Panzyga |
| 68982-0822-05 | Panzyga |
| 68982-0822-06 | Panzyga |
Change History
Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.
-
New Code 2023-Q3Inj, panzyga, 500 mg